Belgian additive manufacturing company Materialise (Nasdaq: MTLS) reported second-quarter 2026 results showing revenue climbing 8.1% year-over-year to €70.073 million, with a 40% jump in aerospace demand doing most of the heavy lifting behind a turnaround in the company's long-struggling Manufacturing segment. The earnings release, published via StockTitan on August 27, also showed the company raising its full-year adjusted EBIT guidance — a sign that management sees the aerospace strength as more than a one-quarter blip.
For a company whose software and manufacturing arms have spent the better part of two years absorbing a slowdown in industrial 3D printing spending, the numbers mark a notable inflection point. First-half revenue reached €136.349 million, up 3.9% from the same period in 2025, and adjusted EBITDA for the quarter rose 15.7% to €9.593 million. Net profit landed at €3.331 million (€0.06 per diluted share) — a sharp improvement over the €199,000 the company posted in the year-ago quarter. Materialise also closed the quarter with €74.214 million in net cash, even after spending €2.903 million on share buybacks. For the first half as a whole, adjusted EBIT climbed 71.4% year-over-year to €6.351 million, net profit reached €5.152 million, and free cash flow came in at €11.368 million — a set of first-half numbers that, taken together, points to margin improvement running ahead of the more modest top-line growth.
Aerospace Pulls Manufacturing Out of the Red
The headline number sits inside Materialise's Manufacturing segment, which supplies industrial parts, tooling, and production services to sectors including aerospace, automotive, and consumer goods. According to a breakdown published by 3DPrint.com's Vanesa Listek, Manufacturing revenue rose 6.7% to €23.6 million in Q2 — a return to growth after a decline in the first quarter of the year. The segment's adjusted EBITDA loss narrowed considerably, from €807,000 in Q2 2025 to €285,000 this quarter, putting the unit within sight of breakeven.
Aerospace and defense demand was the clear driver. Revenue tied to aerospace work surged 40% during the quarter, growth that 3DPrint.com's reporting ties to aerospace and defense customers moving beyond early-stage additive manufacturing adoption toward larger-scale use — a shift CEO Brigitte de Vet-Veithen described directly on the earnings call.
CEO Brigitte de Vet-Veithen framed the shift as aerospace customers already running a base of additive manufacturing wanting to "get to the next level, scale, do more and more parts with it" — language that suggests parts once treated as one-off replacements or low-volume tooling are increasingly being specified for repeat production runs.
That distinction matters for anyone tracking industrial AM adoption. Aerospace has long been considered one of the more conservative sectors when it comes to certifying 3D-printed parts for flight-critical or even non-critical applications, given the qualification overhead involved. A 40% jump in a single quarter, if sustained, would indicate that qualification pipelines built up over the past several years are starting to convert into steady order volume rather than one-off program wins.
Medical Keeps Compounding, Software Cools
Materialise's Medical segment — its largest and historically most stable business, covering surgical planning, patient-specific implants, and point-of-care software for hospitals — posted €36.9 million in revenue, up 12.2% year-over-year. That continues a pattern of double-digit growth for the unit and reinforces it as the company's most dependable earner even as the industrial side of the business has been choppier.
The Software segment was the outlier in the other direction. Revenue there fell 2.7% to €9.6 million, which 3DPrint.com's reporting attributes to weaker U.S. academic customer demand following research grant reductions and reimbursement changes affecting orthopedic customers. Materialise's software portfolio includes Magics and other build-preparation and workflow tools widely used across the professional and industrial 3D printing space, along with medical-specific planning software — so weakness here is worth watching separately from the hardware-adjacent segments, since it reflects budget conditions inside research institutions and healthcare providers rather than manufacturing throughput.
Guidance Raised, But Not the Top Line
Materialise held its full-year 2026 revenue guidance steady at €273–283 million, meaning the company isn't yet forecasting a step-change in top-line growth for the rest of the year. What it did raise is the more telling number: adjusted EBIT guidance moved up to a range of €12–14 million, from a prior €10–12 million. In practical terms, management is signaling that the same or similar revenue this year should convert to meaningfully more profit — consistent with a Manufacturing segment that's shrinking its losses and an aerospace mix that presumably carries better margins than lower-value industrial work.
What It Means for Makers
Materialise doesn't sell desktop printers, and its aerospace and medical customers are a world away from a garage Prusa or Bambu setup. But the results are still a useful signal for anyone paying attention to where the broader additive manufacturing industry is heading. A sustained aerospace ramp at a company like Materialise typically shows up downstream in the wider AM ecosystem — more demand for high-performance polymers and metal powders, more investment in post-processing and qualification tooling, and more engineering talent cycling through industrial AM roles who eventually bring that knowledge into smaller shops and the hobbyist space.
The Software segment softness is arguably the more directly relevant data point for the maker community, even if the dollar amounts are smaller. Reimbursement pressure on orthopedic device customers and softer U.S. academic spending are exactly the kind of institutional belt-tightening that tends to show up later in university makerspaces, research lab equipment purchases, and the pipeline of new engineers being trained on professional-grade tools before they start tinkering at home. It's not a crisis signal, but it's a reminder that the industrial AM recovery is uneven — strong in aerospace, resilient in medical, softer wherever academic and institutional budgets are involved.
For investors and industry watchers, the bigger story is that a company whose Manufacturing segment has bled money for years is now within €285,000 of breakeven on that unit, with management pointing to a specific, durable-looking cause rather than a one-time contract. If aerospace customers really are moving from an early base of additive manufacturing use to running "more and more parts" through it, that's the kind of shift that tends to compound over several quarters rather than reverse itself.
